Page last updated: 2024-10-31

mexiletine and Ventricular Dysfunction

mexiletine has been researched along with Ventricular Dysfunction in 1 studies

Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.

Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.

Research Excerpts

ExcerptRelevanceReference
"Brugada syndrome is characterized by an ST segment elevation in leads V1-V3 and a high incidence of ventricular fibrillation (VF)."2.69Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. ( Aihara, N; Antzelevitch, C; Kamakura, S; Kurita, T; Shimizu, W; Sunagawa, K; Suyama, K; Taguchi, A; Takaki, H, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimizu, W1
Antzelevitch, C1
Suyama, K1
Kurita, T1
Taguchi, A1
Aihara, N1
Takaki, H1
Sunagawa, K1
Kamakura, S1

Trials

1 trial available for mexiletine and Ventricular Dysfunction

ArticleYear
Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Journal of cardiovascular electrophysiology, 2000, Volume: 11, Issue:12

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Bundle-Branch Block; Disopyramide; Electrocardiography; Flecain

2000